pH regulators and their inhibitors in tumor microenvironment

被引:13
作者
Liao, Senyi [1 ]
Wu, Guang [2 ]
Xie, Zhizhong [1 ]
Lei, Xiaoyong [1 ]
Yang, Xiaoyan [1 ]
Huang, Sheng [4 ]
Deng, Xiangping [3 ]
Wang, Zhe [2 ]
Tang, Guotao [1 ]
机构
[1] Univ South China, Inst Pharm & Pharmacol, Hengyang Med Sch, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Pharm, Hengyang 421001, Hunan, Peoples R China
[3] Univ South China, Hengyang Med Sch, Dept Pharm, Affiliated Hosp 1, Hengyang 421001, Hunan, Peoples R China
[4] Jiuzhitang Co Ltd, Changsha 410007, Hunan, Peoples R China
关键词
Tumor microenvironment; pH regulators; Monocarboxylate transportors; Carbonic anhydrase IX; Na plus /H plus exchanger 1; Structure-activity relationship; CARBONIC-ANHYDRASE IX; MONOCARBOXYLATE TRANSPORTER 1; NA+/H+ EXCHANGE INHIBITOR; MATRIX-METALLOPROTEINASE INHIBITORS; SELECTIVE INHIBITORS; ISOFORMS IX; BIOLOGICAL EVALUATION; LACTIC-ACID; GAMMA-HYDROXYBUTYRATE; STRUCTURAL INSIGHTS;
D O I
10.1016/j.ejmech.2024.116170
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As an important characteristic of tumor, acidic tumor microenvironment (TME) is closely related to immune escape, invasion, migration and drug resistance of tumor. The acidity of the TME mainly comes from the acidic products produced by the high level of tumor metabolism, such as lactic acid and carbon dioxide. pH regulators such as monocarboxylate transporters (MCTs), carbonic anhydrase IX (CA IX), and Na+/H+ exchange 1 (NHE1) expel protons directly or indirectly from the tumor to maintain the pH balance of tumor cells and create an acidic TME. We review the functions of several pH regulators involved in the construction of acidic TME, the structure and structure-activity relationship of pH regulator inhibitors, and provide strategies for the development of small-molecule antitumor inhibitors based on these targets.
引用
收藏
页数:32
相关论文
共 239 条
  • [1] Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis
    Abdelrahman, Mohamed A.
    Ibrahim, Hany S.
    Nocentini, Alessio
    Eldehna, Wagdy M.
    Bonardi, Alessandro
    Abdel-Aziz, Hatem A.
    Gratteri, Paola
    Abou-Seri, Sahar M.
    Supuran, Claudiu T.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [2] The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer
    Abe, Yukio
    Nakayama, Yoshifumi
    Katsuki, Takefumi
    Inoue, Yuzuru
    Minagawa, Noritaka
    Torigoe, Takayuki
    Higure, Aiichiro
    Sako, Tatsuhiko
    Nagata, Naoki
    Hirata, Keiji
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (02) : E49 - E55
  • [3] Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
    Abo-Ashour, Mahmoud E.
    Eldehna, Wagdy M.
    Nocentini, Alessio
    Ibrahim, Hany S.
    Bua, Silvia
    Abou-Seri, Sahar M.
    Supuran, Claudiu T.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 28 - 36
  • [4] Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1
    Ahmad, S
    Ngu, K
    Combs, DW
    Wu, SC
    Weinstein, DS
    Liu, W
    Chen, BC
    Chandrasena, G
    Dorso, CR
    Kirby, M
    Atwal, KS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 177 - 180
  • [5] Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1
    Ahmad, S
    Doweyko, LM
    Dugar, S
    Grazier, N
    Ngu, K
    Wu, SC
    Yost, KJ
    Chen, BC
    Gougoutas, JZ
    DiMarco, JD
    Lan, SJ
    Gavin, BJ
    Chen, AY
    Dorso, CR
    Serafino, R
    Kirby, M
    Atwal, KS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (20) : 3302 - 3310
  • [6] Flavonoid structure-activity studies identify 6-prenyichrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2
    Ahmed-Belkacem, A
    Pozza, A
    Muñoz-Martínez, F
    Bates, SE
    Castanys, S
    Gamarro, F
    Di Pietro, A
    Pérez-Victoria, JM
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4852 - 4860
  • [7] Cardioprotective effect of TY-12533, a novel Na+/H+ exchange inhibitor, on ischemia/reperfusion injury
    Aihara, K
    Hisa, H
    Sato, T
    Yoneyama, F
    Sasamori, J
    Yamaguchi, F
    Yoneyama, S
    Mizuno, Y
    Takahashi, A
    Nagai, A
    Kimura, T
    Kogi, K
    Satoh, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (1-2) : 221 - 229
  • [8] Synthesis, Crystal Structure, Inhibitory Activity and Molecular Docking of Coumarins/Sulfonamides Containing Triazolyl Pyridine Moiety as Potent Selective Carbonic Anhydrase IX and XII Inhibitors
    Aimene, Yassine
    Eychenne, Romain
    Rodriguez, Frederic
    Mallet-Ladeira, Sonia
    Saffon-Merceron, Nathalie
    Winum, Jean-Yves
    Nocentini, Alessio
    Supuran, Claudiu T.
    Benoist, Eric
    Seridi, Achour
    [J]. CRYSTALS, 2021, 11 (09)
  • [9] CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells
    Ames, Samantha
    Andring, Jacob T.
    McKenna, Robert
    Becker, Holger M.
    [J]. ONCOGENE, 2020, 39 (08) : 1710 - 1723
  • [10] Ames Samantha, 2018, Oncotarget, V9, P27940, DOI 10.18632/oncotarget.25371